Natural History and Treatment of Herpes Zoster

Journal of Pain

Volumn 9, Issue 1 SUPPL., 2008, Pages 3-9

  Schmader, Kenneth E ^a   Dworkin, Robert H ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

aged; Herpes zoster; pain

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; BUPIVACAINE; CORTICOSTEROID; DESIPRAMINE; FAMCICLOVIR; FOSCARNET; GABAPENTIN; METHYLPREDNISOLONE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; PARACETAMOL; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR;

AGING; ANTICHOLINERGIC EFFECT; ARTICLE; ATAXIA; BALANCE DISORDER; COGNITIVE DEFECT; CONSTIPATION; DISEASE COURSE; DIZZINESS; DROWSINESS; DYSPEPSIA; EDEMA; GASTROINTESTINAL SYMPTOM; GRANULOCYTOSIS; HERPES ZOSTER; HUMAN; INCIDENCE; NAUSEA; NERVE BLOCK; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; PERIPHERAL EDEMA; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; UNITED STATES; URINE RETENTION; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

ADRENAL CORTEX HORMONES; ANALGESICS; ANTIVIRAL AGENTS; HERPES ZOSTER; HUMANS; PAIN;

EID: 37349085166     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2007.10.002     Document Type: Article

References (63)

1. Arani R.B., Soong S.-J., Weiss H.L., Wood M.J., Fiddian P.A., Gnann J.W., and Whitley R. Phase specific analysis of herpes zoster associated pain data: A new statistical approach. Stat Med 20 (2001) 2429-2439
2. Arvin A.M. Varicella-zoster virus. Clin Microbiol Rev 9 (1996) 361-381
3. Berry J.D., and Petersen K.L. A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 65 (2005) 444-447
4. Beutner K.R., Friedman D.J., Forszpaniak C., Andersen P.L., and Wood M.J. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39 (1995) 1546-1553
5. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 13 (1997) 327-331
6. Burgoon Jr. C.F., Burgoon J.S., and Baldridge G.D. The natural history of herpes zoster. JAMA 164 (1957) 265-269
7. Chidiac C., Bruxelle J., Daures J.P., Hoang-Xuan T., Morel P., Leplége A., El Hasnaouri A., and de Labareyre C. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33 (2001) 62-69
8. Coplan P.M., Schmader K., Nikas A., Chan I.S., Choo P., Levin M.J., Johnson G., Bauer M., Williams H.M., Kaplan K.M., Guess H.A., and Oxman M.N. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory. J Pain 5 (2004) 344-356
9. Decroix J., Partsch H., Gonzalez R., Mobacken H., Gohs C.L., Walsh J.B., Shuklaz S., Naisbett B., and Valaciclovir International Zoster Assessment Group (VIZA). Factors influencing pain outcome in herpes zoster: An observational study with valaciclovir. J Eur Acad Dermatol Venereol 14 (2000) 23-33
10. Degreef H., and Famciclovir Herpes Zoster Clinical Study Group. Famciclovir, a new oral antiherpes drug: Results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrob Agents 4 (1994) 241-246
11. Desmond R.A., Weiss H.L., Arani R.B., Soong S.-J., Wood M.J., Fiddian P.A., Gnann J.W., and Whitley R.J. Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage 23 (2002) 510-516
12. Dworkin R.H., Boon R.J., Griffin D.R., and Phung D. Postherpetic neuralgia: Impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 178 suppl 1 (1998) S76-S80
13. Dworkin R.H., Johnson R.W., Breuer J., Gnann J.W., Levin M.J., Backonja M., Betts R.F., Gershon A.A., Haanpää M.L., McKendrick M.W., Nurmikko T.J., Oaklander A.L., Oxman M.N., Pavan-Langston D., Petersen K.L., Rowbotham M.C., Schmader K.E., Stacy B.R., Tyring S.K., von Wijck A.J., Wallace M.S., Wassilew S.W., and Whitley R.J. Recommendations for the management of herpes zoster. Clin Infect Dis 44 suppl 1 (2007) S1-S26
14. Dworkin R.H., Nagasako E.M., Johnson R.W., and Griffin D.R. Acute pain in herpes zoster: The famciclovir database project. Pain 94 (2001) 113-119
15. Dworkin R.H., Perkins F.M., and Nagasako E.M. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain 16 (2000) S90-S100
16. Dworkin R.H., and Portenoy R.K. Proposed classification of herpes zoster pain. Lancet 343 (1994) 1648
17. Dworkin R.H., and Schmader K.E. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson C.P., and Gershon A.A. (Eds). Herpes Zoster and Postherpetic Neuralgia. 2nd ed. (2001), Elsevier, New York 39-64
18. Dworkin R.H., and Schmader K.E. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 36 (2003) 877-882
19. Gilden D.H., Dueland A.N., Cohrs R., Martin J.R., Kleinschmidt-DeMasters B.K., and Mahalingam R. Preherpetic neuralgia. Neurology 41 (1991) 1215-1218
20. Gilden D.H., Dueland A.N., Devlin M.E., Mahalingam R., and Cohrs R. Varicella-zoster virus reactivation without rash. J Infect Dis 166 suppl 1 (1992) S30-S34
21. Gilden D.H., Kleinschmidt-DeMasters B.K., LaGuardia J.J., Mahalingam R., and Cohrs R.J. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342 (2000) 635-645
22. Gilden D.H., Wright R.R., Schneck S.A., Gwaltney Jr. J.M., and Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 35 (1994) 530-533
23. Glesby M.J., Moore R.D., and Chaisson R.E. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis 21 (1995) 370-375
24. Gnann Jr. J.W., and Whitley R.J. Clinical practice: Herpes zoster. N Engl J Med 347 (2002) 340-346
25. Haanpää M., Häkkinen V., and Nurmikko T. Motor involvement in acute herpes zoster. Muscle Nerve 20 (1997) 1433-1438
26. Haanpää M., Laippala P., and Nurmikko T. Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain 15 (1999) 78-84
27. Haanpää M., Laippala P., and Nurmikko T. Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J Pain Symptom Manage 20 (2000) 50-58
28. Hempenstall K., Nurmikko T.J., Johnson R.W., A'Hern R.P., and Rice A.S. Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Med 2 (2005) e164
29. Hope-Simpson R. Studies on shingles: Is the virus ordinary chicken pox virus?. Lancet (1954) 1299-1302
30. Hope-Simpson R. The nature of herpes zoster: A long-term study and a new hypothesis. Proc R Soc Med 58 (1965) 9-20
31. Jackson J.L., Gibbons R., Meyer G., and Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: A meta-analysis. Arch Intern Med 157 (1997) 909-912
32. Jacobson M.A., Berger T.G., Fikrig S., Beckerer P., Moohr J.W., Stanat S.C., and Biran K.K. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 112 (1990) 187-191
33. Jung B.F., Johnson R.W., Griffin D.R., and Dworkin R.H. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62 (2004) 1545-1551
34. Katz J., Cooper E.M., Walther R.R., Sweeney E.W., and Dworkin R.H. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39 (2004) 342-348
35. Kost R.G., and Straus S.E. Postherpetic neuralgia: pathogenesis, treatment, and prevention. N Engl J Med 335 (1996) 32-42
36. Kurokawa I., Kumano K., and Murakawa K. Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J Int Med Res 30 (2002) 56-65
37. Kurtzke J.F. Neuroepidemiology. Ann Neurol 16 (1984) 265-277
38. Lewis G.W. Zoster sine herpete. Br Med J 2 (1958) 418-421
39. Liesegang T.J. Varicella-zoster virus eye disease. Cornea 18 (1999) 511-531
40. Lydick E., Epstein R.S., Himmelberger D., and White C.J. Herpes zoster and quality of life: A self-limited disease with severe impact. Neurology 45 (1995) S52-S53
41. Mauskopf J., Austin R., Dix L., and Berzon R. The Nottingham Health Profile as a measure of quality of life in zoster patients: Convergent and discriminant validity. Qual Life Res 3 (1994) 431-435
42. McCrary M.L., Severson J., and Tyring S.K. Varicella zoster virus. J Am Acad Dermatol 41 (1999) 1-14
43. McKendrick M.W., Care C.C., Kudesia G., Bates C.J., Oxley M.K., and Eley A. Is VZV reactivation a common cause of unexplained unilateral pain?. Results of a prospective study of 57 patients. J Infect 39 (1999) 209-212
44. Mehta S.K., Cohrs R.J., Forghani B., Zerbe G., Gilden D.H., and Pierson D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 72 (2004) 174-179
45. Nagasako E.M., Johnson R.W., Griffin D.R., and Dworkin R.H. Rash severity in herpes zoster: Correlates and relationship to postherpetic neuralgia. J Am Acad Dermatol 46 (2002) 834-839
46. Oaklander A.L., Bowsher D., Galer B., Haanpää M., and Jensen M.P. Herpes zoster itch: Preliminary epidemiologic data. J Pain 4 (2003) 338-343
47. Oaklander A.L., and Rissmiller J.G. Postherpetic neuralgia after shingles: An under-recognized cause of chronic vulvar pain. Obstet Gynecol 99 (2002) 625-628
48. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Gelb L.D., Arbeit R.D., Simberkoff M.S., Gershon A.A., Davis L.E., Weinberg A., Boardman K.D., Williams H.M., Zhang J.H., Peduzzi P.N., Beisel C.E., Morrison V.A., Guatelli J.C., Brooks P.A., Kauffman C.A., Pachucki C.T., Neuzil K.M., Betts R.F., Wright P.F., Griffin M.R., Brunell P., Soto N.E., Marques A.R., Keay S.K., Goodman R.P., Cotton D.J., Gnann Jr. J.W., Loutit J., Holodniy M., Keitel W.A., Crawford G.E., Yeh S.-S., Lobo Z., Toney J.F., Greenberg R.N., Keller P.M., Harbecke R., Hayward A.R., Irwin M.R., Kyriakides T.C., Chan C.Y., Chan I.S., Wang W.W., Annunziato P.W., Silber J.L., and Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
49. Ragozzino M.W., Melton III L.J., Kurland L.T., Chu C.P., and Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 61 (1982) 310-316
50. Schmader K., George L.K., Burchett B.M., Hamilton J.D., and Pieper C.F. Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc 46 (1998) 973-977
51. Schmader K., Studenski S., MacMillan J., Grufferman S., and Cohen H.J. Are stressful life events risk factors for herpes zoster?. J Am Geriatr Soc 38 (1990) 1188-1194
52. Schmader KE, Watson CP, Gnann JW: Epidemiological and clinical rationale for the herpes zoster vaccine. J Infect Dis 2007; In press
53. Straus S.E., Reinhold W., Smith H.A., Ruyechan W.T., Henderson D.K., Blaese R.M., and Hay J. Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N Engl J Med 311 (1984) 1362-1364
54. Thomas S.L., and Hall A.J. What does epidemiology tell us about risk factors for herpes zoster?. Lancet Infect Dis 4 (2004) 26-33
55. Thomas S.L., Wheeler J.G., and Hall A.J. Case-control study of the effect of mechanical trauma on the risk of herpes zoster. BMJ 328 (2004) 439
56. Tyring S., Barbarash R.A., Nahlik J.E., Cunningham A., Marley J., Heng M., Jones T., Rea T., Boon R., Saltzman R., and Collaborative Famciclovir Herpes Zoster Study Group. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123 (1995) 89-96
57. Tyring S.K., Beutner K.R., Tucker B.A., Anderson W.C., and Crooks R.J. Antiviral therapy for herpes zoster: Randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9 (2000) 863-869
58. van Wijck A.J., Opstelten W., Moons K.G., van Essen G.A., Stalker R.J., Kalkman C.J., and Verheij T.J. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: A randomised controlled trial. Lancet 367 (2006) 219-224
59. Weller T., Witton H., and Bell E. The etiologic agents of varicella and herpes zoster: Isolation, propagation, and cultural characteristics in vitro. J Exp Med 108 (1958) 843-868
60. Whitley R.J., Weiss H., Gnann Jr. J.W., Tyring S., Mertz G.J., Pappas P.G., Schleupner C.J., Hayden F., Wolf J., and Soong S.-J. Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial. Ann Intern Med 125 (1996) 376-383
61. Wood M.J., Johnson R.W., McKendrick M.W., Taylor J., Mandal B.K., and Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330 (1994) 896-900
62. Wood M.J., Kay R., Dworkin R.H., Soong S.J., and Whitley R.J. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials. Clin Infect Dis 22 (1996) 341-347
63. Zaal M.J., Völker-Dieben H.J., Wienesen M., D'Amaro J.D., and Kijlstra A. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus. Am J Ophthalmol 131 (2001) 25-29